Whole blood serotonin and platelet activation in depressed post-myocardial infarction patients

Life Sciences

Volumn 76, Issue 6, 2004, Pages 637-650

  Schins, Annique ^a   Hamulyák, Karly ^a   Scharpé, Simon ^b   Lousberg, Richel ^a   Van Melle, Joost ^c   Crijns, Harry ^a   Honig, Adriaan ^d  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d Department of Psychiatry   (Netherlands)

Author keywords

thromboglobulin; Depression; Myocardial infarction; Platelet activation

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA THROMBOGLOBULIN; CALCIUM CHANNEL BLOCKING AGENT; CD40 LIGAND; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; MIRTAZAPINE; PLACEBO; SEROTONIN; STATIN; THROMBOCYTE FACTOR 4;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART INFARCTION; HUMAN; MALE; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE ACTIVATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ANTIGENS, CD40; BETA-THROMBOGLOBULIN; DEPRESSIVE DISORDER; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LIGANDS; MALE; MIANSERIN; MIDDLE AGED; MYOCARDIAL INFARCTION; PLATELET ACTIVATION; PLATELET FACTOR 4; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN;

EID: 9644257096     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2004.04.060     Document Type: Article

References (67)

1. H. Al Mardini, E.J. Harrison, P.G. Ince, K. Bartlett, and C.O. Record Brain indoles in human hepatic encephalopathy Hepatology 17 1993 1033 1040
2. G.M. Anderson, J.G. Young, D.J. Cohen, K.R. Schlicht, and N. Patel Liquid-chromatographic determination of serotonin and tryptophan in whole blood and plasma Clinical Chemistry 27 1981 775 776
3. P. Andre, L. Nannizzi-Alaimo, S.K. Prasad, and D.R. Phillips Platelet-derived CD40L: the switch-hitting player of cardiovascular disease Circulation 106 2002 896 899
4. S.A. Anttila, and E.V. Leinonen A review of the pharmacological and clinical profile of mirtazapine CNS Drug Reviews 7 2001 249 264
5. P. Aukrust, F. Muller, T. Ueland, T. Berget, E. Aaser, A. Brunsvig, N.O. Solum, K. Forfang, S.S. Froland, and L. Gullestad Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes Circulation 100 1999 614 620
6. J.C. Barefoot, and M. Schroll Symtomps of depression, acute myocardial infarction, and total mortality in a community sample Circulation 93 1996 1976 1980
7. D. Bereczki, E. Nagy, A. Pal, M.T. Magyar, and J. Balla Should soluble CD40 ligand be measured from serum or plasma samples? Arteriosclerosis, Thrombosis, and Vascular Biology 23 2003 1129 1130 (author reply 1130-1131)
8. L.F. Berkman, J. Blumenthal, M. Burg, R.M. Carney, D. Catellier, M.J. Cowan, S.M. Czajkowski, R. DeBusk, J. Hosking, A. Jaffe, P.G. Kaufmann, P. Mitchell, J. Norman, L.H. Powell, J.M. Raczynski, and N. Schneiderman Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial Journal of the American Medical Association 289 2003 3106 3116
9. D.E. Bush, R.C. Ziegelstein, M. Tayback, D. Richter, S. Stevens, H. Zahalsky, and J.A. Fauerbach Even minimal symptoms of depression increase mortality risk after acute myocardial infarction American Journal of Cardiology 88 2001 337 341
10. S.O. Dalton, C. Johansen, L. Mellemkjaer, B. Norgard, H.T. Sorensen, and J.H. Olsen Use of selective serotonin reuptake inhibitors and risk of upper gastrointestinal tract bleeding: a population-based cohort study Archives of Internal Medicine 163 2003 59 64
11. F.J. de Abajo, L.A. Rodriguez, and D. Montero Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study British Medical Journal 319 1999 1106 1109
12. S.M. Delisi, L.M. Konopka, F.L. O'Connor, and J.W. Crayton Platelet cytosolic calcium responses to serotonin in depressed patients and controls: relationship to symptomatology and medication Biological Psychiatry 43 1998 327 334
13. H. D'haenen, A. Bossuyt, J. Mertens, C. Bossuyt-Piron, M. Gijsemans, and L. Kaufman SPECT imaging of serotonin2 receptors in depression Psychiatry Research 45 1992 227 237
14. A. Eckert, H. Gann, D. Riemann, J. Aldenhoff, and W.E. Muller Elevated intracellular calcium levels after 5-HT2 receptor stimulation in platelets of depressed patients Biological Psychiatry 34 1993 565 568
15. L. Franke, H.J. Schewe, B. Muller, V. Campman, W. Kitzrow, R. Uebelhack, A. Berghofer, and B. Muller-Oerlinghausen Serotonergic platelet variables in unmedicated patients suffering from major depression and healthy subjects: relationship between 5HT content and 5HT uptake Life Sciences 67 2000 301 305
16. T.P. Gavaghan, J.B. Hickie, S.A. Krilis, D.W. Baron, V. Gebski, J. Low, and C.N. Chesterman Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin Journal of the American College of Cardiology 15 1990 1250 1258
17. A.H. Glassman, C.M. O'Connor, R.M. Califf, K. Swedberg, P. Schwartz, J.T. Bigger Jr., K.R. Krishnan, L.T. van Zyl, J.R. Swenson, M.S. Finkel, C. Landau, P.A. Shapiro, C.J. Pepine, J. Mardekian, W.M. Harrison, D. Barton, and M. McLvor Sertraline treatment of major depression in patients with acute MI or unstable angina Journal of the American Medical Association 288 2002 701 709
18. D. Gurney, G.Y. Lip, and A.D. Blann A reliable plasma marker of platelet activation: does it exist? American Journal of Hematology 70 2002 139 144
19. Hair, J.F. 1998. Multivariate data analysis. (eds J.F. Hair, R.E. Anderson, R.L. Tatham and W.C. Black). Upper Saddle River, New Jersey: Prentice-Hall, Inc. A. Simon&Schuster Company.
20. G.L. Hanna, J.A. Himle, G.C. Curtis, D.Q. Koram, J. Veenstra-VanderWeele, B.L. Leventhal, and E.H. Cook Jr. Serotonin transporter and seasonal variation in blood serotonin in families with obsessive-compulsive disorder Neuropsychopharmacology 18 1998 102 111
21. A. Honig, R. Lousberg, F. Wojchiechowski, E.C. Cheriex, H. Wellens, and H.M. Van Praag Depression following a first myocardial infarction; similarities with and difference from 'ordinary' depression Depressie na een eerste hartinfarct: overeenkomsten en verschillen met een gewone depressie Nederlandsch Tijdschrift voor Geneeskunde 141 1997 196 199
22. M. Humble, S. Bejerot, P.B. Bergqvist, and F. Bengtsson Reactivity of serotonin in whole blood: relationship with drug response in obsessive-compulsive disorder Biological Psychiatry 49 2001 360 368
23. D.P. Inwald, A. McDowall, M.J. Peters, R.E. Callard, and N.J. Klein CD40 is constitutively expressed on platelets and provides a novel mechanism for platelet activation Circulation Research 92 2003 1041 1048
24. T. Itoh, K. Nakai, M. Ono, and K. Hiramori Can the risk for acute cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin? Coronary Artery Disease 6 1995 645 650
25. L.M. Konopka, R. Cooper, and J.W. Crayton Serotonin-induced increases in platelet cytosolic calcium concentration in depressed, schizophrenic, and substance abuse patients Biological Psychiatry 39 1996 708 713
26. A.M. Kumar, M. Kumar, K. Deepika, J.B. Fernandez, and C. Eisdorfer A modified HPLC technique for simultaneous measurement of 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in cerebrospinal fluid, platelet and plasma Life Sciences 47 1990 1751 1759
27. F. Laghrissi-Thode, W.R. Wagner, B.G. Pollock, P.C. Johnson, and M.S. Finkel Elevated platelet factor 4 and beta-thromboglobulin plasma levels in depressed patients with ischemic heart disease Biological Psychiatry 42 1997 290 295
28. K.H. Le Quan-Bui, O. Plaisant, M. Leboyer, C. Gay, L. Kamal, M.A. Devynck, and P. Meyer Reduced platelet serotonin in depression Psychiatry Research 13 1984 129 139
29. S.P. Levine, B.L. Towell, A.M. Suarez, L.K. Knieriem, M.M. Harris, and J.N. George Platelet activation and secretion associated with emotional stress Circulation 71 1985 1129 1134
30. S.B. Malkoff, M.F. Muldoon, Z.R. Zeigler, and S.B. Manuck Blood platelet responsivity to acute mental stress Psychosomatic Medicine 55 1993 477 482
31. J.H. Markovitz, K.A. Matthews, J. Kiss, and T.C. Smitherman Effects of hostility on platelet reactivity to psychological stress in coronary heart disease patients and in healthy controls Psychosomatic Medicine 58 1996 143 149
32. J.H. Markovitz, J.L. Shuster, W.S. Chitwood, R.S. May, and L.C. Tolbert Platelet activation in depression and effects of sertraline treatment: an open-label study American Journal of Psychiatry 157 2000 1006 1008
33. E. Maurer-Spurej, C. Pittendreigh, and K. Solomons The influence of selective serotonin reuptake inhibitors on human platelet serotonin Thrombosis and Haemostasis 91 2004 119 128
34. H.S. Mayberg, R.G. Robinson, D.F. Wong, R. Parikh, P. Bolduc, S.E. Starkstein, T. Price, R.F. Dannals, J.M. Links, A.A. Wilson, H.T. Ravert, and H.N. Wagner PET imaging of cortical S2 serotonin receptors after stroke: lateralized changes and relationship to depression American Journal of Psychiatry 145 1988 937 943
35. J. Mehta, and P. Mehta Effects of propranolol therapy on platelet release and prostaglandin generation in patients with coronary heart disease Circulation 66 1982 1294 1299
36. S.D. Mendelson The current status of the platelet 5-HT(2A) receptor in depression Journal of Affective Disorders 57 2000 13 24
37. K. Miyata, H. Shimokawa, T. Higo, T. Yamawaki, N. Katsumata, T. Kandabashi, E. Tanaka, Y. Takamura, K. Yogo, K. Egashira, and A. Takeshita Sarpogrelate, a selective 5-HT2A serotonergic receptor antagonist, inhibits serotonin-induced coronary artery spasm in a porcine model Journal of Cardiovascular Pharmacology 35 2000 294 301
38. D. Muck-Seler, M. Jakovljevic, and Z. Deanovic Effect of antidepressant treatment on platelet 5-HT content and relation to therapeutic outcome in unipolar depressive patients Journal of Affective Disorders 23 1991 157 164
39. D. Muck-Seler, M. Jakovljevic, and Z. Deanovic Platelet serotonin in subtypes of schizophrenia and unipolar depression Psychiatry Research 38 1991 105 113
40. D. Muck-Seler, M. Jakovljevic, and N. Pivac Platelet 5-HT concentrations and suicidal behaviour in recurrent major depression Journal of Affective Disorders 39 1996 73 80
41. D.L. Musselman, U.M. Marzec, A. Manatunga, S. Penna, A. Reemsnyder, B.T. Knight, A. Baron, S.R. Hanson, and C.B. Nemeroff Platelet reactivity in depressed patients treated with paroxetine: preliminary findings Archives of General Psychiatry 57 2000 875 882
42. D.L. Musselman, A. Tomer, A.K. Manatunga, B.T. Knight, M.R. Porter, S. Kasey, U. Marzec, L.A. Harker, and C.B. Nemeroff Exaggerated platelet reactivity in major depression American Journal of Psychiatry 153 1996 1313 1317
43. G.V. Nair, P.A. Gurbel, C.M. O'Connor, W.A. Gattis, S.R. Murugesan, and V.L. Serebruany Depression, coronary events, platelet inhibition, and serotonin reuptake inhibitors American Journal of Cardiology 84 1999 321 323 (A8)
44. T. Nilsson, J. Longmore, D. Shaw, E. Pantev, J.A. Bard, T. Branchek, and L. Edvinsson Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques European Journal of Pharmacology 372 1999 49 56
45. M.J. Owens, and C.B. Nemeroff Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter Clinical Chemistry 40 1994 288 295
46. R. Pakala, J.T. Willerson, and C.R. Benedict Mitogenic effect of serotonin on vascular endothelial cells Circulation 90 1994 1919 1926
47. G.N. Pandey, S.C. Pandey, Y. Dwivedi, R.P. Sharma, P.G. Janicak, and J.M. Davis Platelet serotonin-2A receptors: a potential biological marker for suicidal behavior American Journal of Psychiatry 152 1995 850 855
48. B.W. Penninx, A.T. Beekman, A. Honig, D.J. Deeg, R.A. Schoevers, J.T. van Eijk, and W. van Tilburg Depression and cardiac mortality: results from a community-based longitudinal study Archives of General Psychiatry 58 2001 221 227
49. V. Perez, N. Bel, P. Celada, J. Ortiz, E. Alvarez, and F. Artigas Relationship between blood serotonergic variables, melancholic traits, and response to antidepressant treatments Journal of Clinical Psychopharmacology 18 1998 222 230
50. J.E. Piletz, H. Zhu, S. Madakasira, P. Pazzaglia, C. Lindsay DeVane, N. Goldman, and A. Halaris Elevated P-selectin on platelets in depression: response to bupropion Journal of Psychiatric Research 34 2000 397 404
51. B.G. Pollock, F. Laghrissi-Thode, and W.R. Wagner Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment Journal of Clinical Psychopharmacology 20 2000 137 140
52. E. Pussard, N. Guigueno, O. Adam, and J.F. Giudicelli Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine Clinical Chemistry 42 1996 1086 1091
53. J. Quintana Platelet serotonin and plasma tryptophan decreases in endogenous depression. Clinical, therapeutic, and biological correlations Journal of Affective Disorders 24 1992 55 62
54. A. Schins, A. Honig, H.J.G.M. Crijns, L.H. Baur, and K. Hamulyak Increased coronary events in depressed cardiovascular patients: 5-HT2A receptor as missing link? Psychosomatic Medicine 65 2003 729 737
55. U. Schonbeck, N. Varo, P. Libby, J. Buring, and P.M. Ridker Soluble CD40L and cardiovascular risk in women Circulation 104 2001 2266 2268
56. V.L. Serebruany, A.H. Glassman, A.I. Malinin, C.B. Nemeroff, D.L. Musselman, L.T. van Zyl, M.S. Finkel, K.R. Krishnan, M. Gaffney, W. Harrison, R.M. Califf, and C.M. O'Connor Platelet/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline AntiDepressant Heart Attack Randomized Trial (SADHART) Platelet Substudy Circulation 108 2003 939 944
57. J.K. Staley, R.T. Malison, and R.B. Innis Imaging of the serotonergic system: interactions of neuroanatomical and functional abnormalities of depression Biological Psychiatry 44 1998 534 549
58. J.R. Stratton, T.W. Malpass, J.L. Ritchie, M.A. Pfeifer, and L.A. Harker Studies of platelet factor 4 and beta thromboglobulin release during exercise: lack of relationship to myocardial ischemia Circulation 66 1982 33 43
59. J.J. Strik, A. Honig, R. Lousberg, J. van Os, E.J. van den Berg, and H.M. van Praag Clinical correlates of depression following myocardial infarction International Journal of Psychiatry in Medicine 31 2001 255 264
60. J.J.M.H. Strik, A. Honig, R. Lousberg, A. Lousberg, E.C. Cheriex, H. Tuynman-Qua, P.M.J.C. Kuijpers, H.J.J. Wellens, and H.M. Van Praag Efficacy and safety of fluoxetine in the treatment of patients with major depression following first myocardial infarction: findings from a double-blind placebo-controlled trial Psychosomatic Medicine 62 2000 783 789
61. M.D. Trip, V.M. Cats, F.J. van Capelle, and J. Vreeken Platelet hyperreactivity and prognosis in survivors of myocardial infarction New England Journal of Medicine 322 1990 1549 1554
62. R.H.S. van den Brink, J. van Melle, A. Honig, A.H. Schene, H.J.G.M. Crijns, F.P.G. Lambert, and J. Ormel Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: Rationale and outline of the Myocardial INfarction and Depression - Intervention Trial (MIND-IT) American Heart Journal 144 2002 219 225
63. C. van Walraven, M.M. Mamdani, P.S. Wells, and J.I. Williams Inhibition of serotonin reuptake by antidepressants and upper gastrointestinal bleeding in elderly patients: retrospective cohort study British Medical Journal 323 2001 655 658
64. P.M. Vanhoutte Platelet-derived serotonin, the endothelium and cardiovascular disease Journal of Cardiovascular Pharmacology 17 suppl. 5 1991 S6 S12
65. K. Vikenes, M. Farstad, and J.E. Nordrehaug Serotonin is associated with coronary artery disease and cardiac events Circulation 100 1999 483 489
66. M.T. Walsh, T.G. Dinan, R.M. Condren, M. Ryan, and D. Kenny Depression is associated with an increase in the expression of the platelet adhesion receptor glycoprotein Ib Life Sciences 70 2002 3155 3165
67. J.T. Willerson, S.K. Yao, J. McNatt, C.R. Benedict, H.V. Anderson, P. Golino, S.S. Murphree, and L.M. Buja Frequency and severity of cyclic flow alternations and platelet aggregation predict the severity of neointimal proliferation following experimental coronary stenosis and endothelial injury Proceedings of the National Academy of Sciences of the United States of America 88 1991 10624 10628